Skip to main content

The control, identification and delivery of prescribed medication

Objective

The problems associated with non-compliance to a prescribed medication regime can have serious implications for the health of the patient and incur unnecessary healthcare costs. It is the aim of the proposed project to investigate the needs of such patients, analyse current methods used to address this problem and develop an innovative care model and associated peripherals to assist with compliance to a medication regimen. The infrastructure of the care model will be centred on an Internet-based control server, providing remote monitoring and control of the patient's regimen. Hardware will be developed for home use, to store the medication, dispense it appropriately and provide a reminder to the patient in cases of non-compliance. A clinical evaluation is proposed to ascertain the potential success in reducing non-compliance by 5-7%.

DESCRIPTION OF WORK
This project entails the development of a medical device and associated care model aimed at the delivery and dispensing of drugs. The device is connected to a dedicated control centre, to which doctors, pharmacists and other registered professionals have access, via a communications network, and thus allows the development of a comprehensive care model.
Implementation of the project involves 5 stages and the main tasks to be undertaken are:
a human factor analysis to appreciate the needs of the user and all other stakeholders;
review the current methodologies employed to assist with non-compliance and the process of Telecare;
develop the MEDICATE care model and its associated peripherals;
gain levels of user acceptance from analysis of prototypes and the final model;
integrate the proposed care model into existing home care scenarios within the target groups;
undertake a series of clinical evaluations to produce a scientific analysis of the proposal.
Dissemination will be initiated at the start and will be used as a means of identifying further potential user groups. Feedback in terms of user requirements and acceptance, through ongoing demonstrations at various prototype levels, will be used as a means of identifying further potential users. Through promotion of the project at these levels, and increasing the awareness in the EU community, the target groups and expected impact can be identified prior to the final product launch. Exploitation of the project will also be initiated at the onset. This will involve on-going market analyses to ensure the product is in line with market trends. Business plans will be generated and reviewed every six months by the industrial partners, in order to gain a full appreciation of the likely outcomes of the project in business terms and its marketability.

MILESTONES
- Initial and refined prototypes for acceptance testing (17&22mths)
- Final prototype and clinical tests (32mths)
- On set of commercialisation (35mths)
The results of MEDICATE will be a fully clinically tested care model to address the issues of non-compliance. The home unit and care model will be ready for exploitation by the industrial partners.

Call for proposal

Data not available

Coordinator

UNIVERSITY OF ULSTER
Address
Cromore Road
BT52 1SA Coleraine
United Kingdom
 

Participants (6)

CENTRE SUISSE D'ELECTRONIQUE ET DE MICROTECHNIQUE SA - RECHERCHE ET DEVELOPPEMENT
Switzerland
Address
Rue Jaquet-droz 1
2007 Neuchatel
 
CONSORZIO ZENIT COOPERATIVA SOCIALE CONSORTILE A R.L.
Italy
Address
Via Casamorata 19
50139 Firenze
 
ERGO S.A.
Greece
Address
16 Ag.orous Street
15123 Maroussi - Athens
 
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
United Kingdom
Address
South Kensington Campus, Exhibition Road
SW7 2AZ London
 
UNIVERSITA DEGLI STUDI DI VERONA
Italy
Address
Via Dell' Artigliere 8
37192 Verona
 
UNIVERSITY OF CYPRUS
Cyprus
Address
Kallipoleos Street 75
1678 Nicosia